Novartis drug Signifor® approved in EU, marking an advance for patients with inadequately controlled acromegaly

World News: . []

Novartis International AG Novartis drug LINK  approved in EU marking an LINK  for patients with inadequately controlled acromegaly Processed and transmitted by LINK  OMX Corporate SolutionsThe issuer is LINK  responsible for the co ntent o...

More news and information about Novartis International AG

Published By:

Thomson Reuters: 06:15 GMT Monday 24th November 2014

Published: .

Search for other references to "novartis" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us